Observation on serumγ-glutamyl transpeptidase levels of patients with sub-clinical schistosomiasis before and after pathogen treatment
10.16250/j.32.1374.2016008
- VernacularTitle:亚临床型血吸虫病患者病原治疗前后血清γ-谷氨酰转肽酶水平观察
- Author:
Shiye LIAO
;
Junjun LI
;
Lijuan XIONG
- Publication Type:Journal Article
- Keywords:
Schistosomiasis;
Subclinical;
Gamma-glutamyl transpeptidase(GGT);
Liver function;
Ezhou City
- From:
Chinese Journal of Schistosomiasis Control
2016;28(5):596-597,605
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the changes of serumγ?glutamyl transpeptidase(GGT)levels before and after the patho?gen treatment in patients with subclinical schistosomiasis,and explore its clinical value in the diagnosis and treatment of sub?clinical schistosomiasis. Methods Totally 109 patients with subclinical schistosomiasis,who were found in the endemic inves?tigation of schistosomiasis in Ezhou City,were selected as the investigation subjects,and then they were treated with praziquan?tel. The serum GGT levels of the subjects before and after the treatment were detected and compared. Results Before the treat?ment,the average value of the GGT levels of the 109 patients was(48.1 ± 45.9)IU/L,among which,the GGT levels of 69 cases (63.3%)were normal,and the levels of 40 cases(36.7%)were increased. After the treatment,the average GGT level of the pa?tients was(32.1 ± 23.4)IU/L,which decreased by 33.3%comparing with that before the treatment,and the difference had a statistical significance(U=2.17,P=0.01). The GGT levels of 65 patients decreased in different degrees. Among the 40 pa?tients whose GGT levels had increased before the treatment,the GGT levels of 31 ones returned to the normal. Conclusion The GGT level detection can accurately reflect the liver function in the patients with subclinical schistosomiasis ,and also it has certain clinical application value to judge the liver function damage and recovery of the patients before and after the pathogen treatment.
